|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naume B, Synnestvedt M, Falk RS, Wiedswang
G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH,
et al: Clinical outcome with correlation to disseminated tumor cell
(DTC) status after DTC-guided secondary adjuvant treatment with
docetaxel in early breast cancer. J Clin Oncol. 32:3848–3857. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tian M, Neil JR and Schiemann WP:
Transforming growth factor-β and the hallmarks of cancer. Cell
Signal. 23:951–962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kahata K, Hayashi M, Asaka M, Hellman U,
Kitagawa H, Yanagisawa J, Kato S, Imamura T and Miyazono K:
Regulation of transforming growth factor-beta and bone
morphogenetic protein signalling by transcriptional coactivator
GCN5. Genes Cells. 9:143–151. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH,
Lee JE, Wang C, Brindle PK, Dent SY and Ge K: Distinct roles of
GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in
nuclear receptor transactivation. EMBO J. 30:249–262. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li S and Shogren-Knaak MA: The Gcn5
bromodomain of the SAGA complex facilitates cooperative and
cross-tail acetylation of nucleosomes. J Biol Chem. 284:9411–9417.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, Wei T, Si X, Wang Q, Li Y, Leng Y,
Deng A, Chen J, Wang G, Zhu S and Kang J: Lysine acetyltransferase
GCN5 potentiates the growth of non-small cell lung cancer via
promotion of E2F1, cyclin D1, and cyclin E1 expression. J Biol
Chem. 288:14510–14521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Germaniuk-Kurowska A, Nag A, Zhao X, Dimri
M, Band H and Band V: Ada3 requirement for HAT recruitment to
estrogen receptors and estrogen-dependent breast cancer cell
proliferation. Cancer Res. 67:11789–11797. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Chen YL, Ji G, Fang W, Gao Z, Liu
Y, Wang J, Ding X and Gao F: Sorafenib inhibits
epithelial-mesenchymal transition through an epigenetic-based
mechanism in human lung epithelial cells. PLoS One. 8:e649542013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu
JY, Allis CD, Marmorstein R and Berger SL: Phosphorylation of
serine 10 in histone H3 is functionally linked in vitro and in vivo
to Gcn5-mediated acetylation at lysine 14. Mol Cell. 5:917–926.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ko H, Jeon H, Lee D, Choi HK, Kang KS and
Choi KC: Sanguiin H6 suppresses TGF-β induction of the
epithelial-mesenchymal transition and inhibits migration and
invasion in A549 lung cancer. Bioorg Med Chem Lett. 25:5508–5513.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen YL, Lv J, Ye XL, Sun MY, Xu Q, Liu
CH, Min LH, Li HP, Liu P and Ding X: Sorafenib inhibits
transforming growth factor β1-mediated epithelial-mesenchymal
transition and apoptosis in mouse hepatocytes. Hepatology.
53:1708–1718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu K, Zhang Q, Lan H, Wang L, Mou P, Shao
W, Liu D, Yang W, Lin Z, Lin Q and Ji T: GCN5 potentiates glioma
proliferation and invasion via STAT3 and AKT signaling pathways.
Int J Mol Sci. 16:21897–21910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choudhary C, Kumar C, Gnad F, Nielsen ML,
Rehman M, Walther TC, Olsen JV and Mann M: Lysine acetylation
targets protein complexes and co-regulates major cellular
functions. Science. 325:834–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peserico A and Simone C: Physical and
functional HAT/HDAC interplay regulates protein acetylation
balance. J Biomed Biotechnol. 2011:3718322011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmierer B and Hill CS: TGFbeta-SMAD
signal transduction: Molecular specificity and functional
flexibility. Nat Rev Mol Cell Biol. 8:970–982. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen ZY, Wang PW, Shieh DB, Chiu KY and
Liou YM: Involvement of gelsolin in TGF-beta 1 induced epithelial
to mesenchymal transition in breast cancer cells. J Biomed Sci.
22:902015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niu G, Wright KL, Huang M, Song L, Haura
E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, et al:
Constitutive Stat3 activity up-regulates VEGF expression and tumor
angiogenesis. Oncogene. 21:2000–2008. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie Y, Naizabekov S, Chen Z and Tokay T:
Power of PTEN/AKT: Molecular switch between tumor suppressors and
oncogenes. Oncol Lett. 12:375–378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo R, Chen J, Mitchell DL and Johnson DG:
GCN5 and E2F1 stimulate nucleotide excision repair by promoting
H3K9 acetylation at sites of damage. Nucleic Acids Res.
39:1390–1397. 2011. View Article : Google Scholar : PubMed/NCBI
|
